UnknownNCT06488586
IV Ketamine vs. IN Esketamine for MDD TRD
Observational studyAges 18–75CanadaDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 75 years.
- Listed locations
- KingstonSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 20, 2023
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 80
- Sponsor
- Gustavo Vazquez
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Drug
- Locations
- Canada
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT06488586
- Official title
Show the full official title
IN Esketamine and IV Ketamine: Multi-site Observational Study Assessing the Effectiveness and Tolerability of Two Novel Therapies for Treatment-resistant Depression.
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Kingston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Gustavo Vazquez.
Does this study involve medication?
Yes. The study involves medication, including Low dose IV Ketamine vs. IN Esketamine.
Who can participate?
Listed age limits: 18 years to 75 years.
